Drugs / CIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02568748 | Oct 2015 → Jun 2019 | liver cancer | Tanta University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02568748 ↗ |
| Modality | Cell therapy | “Cytokine-induced killer CIK cells therapy has been evaluated as an adoptive cell immunotherapy for cancer patients” NCT02568748 ↗ |
| Route | Other | “Infusion will be given intrahepatic” NCT02568748 ↗ |